NEW YORK (GenomeWeb News) - Rules Based Medicine has won an $849,000 fast-track grant from the National Institute for General Medical Sciences to develop a test through a collaboration with the University of New Mexico in Albuquerque that would diagnose neonatal sepsis.
The company said that it will perform all of the testing and statistical analysis on samples provided by the University of New Mexico’s Neonatal Intensive Care ward. Specifically, RBM will use its HumanMAP platform to characterize and validate a pattern of biomarkers that can detect early signs of infection in newborns.
“The ability to routinely monitor serum biomarkers for the earliest signs of infection could have a significant impact on the survival rates of the newborns most at risk,” said UNM Professor of Medicine Clifford Lyons.